工程治疗细菌具有高产率的膜囊泡生产灵感来自于真核生物膜曲率治疗炎症性肠病的治疗细菌
Jinjin Chen1, Mingkang Liu2, Shiyi Chen2
1Department of Chemical Engineering, University of Waterloo, 200 University Avenue West, Waterloo, Ontario N2L 3G1, Canada.
ACS nano
|January 8, 2025
概括
工程细菌高效地产生细菌膜囊泡 (BMVs),用于潜在的治疗用途. 这一突破克服了生产挑战,为治疗炎症性肠病 (IBD) 提供了有前途的新途径.
科学领域:
- 生物技术是生物技术.
- 纳米技术纳米技术
- 微生物学 微生物学
背景情况:
- 细菌膜囊泡 (BMVs) 是具有重要的医疗和工业潜力的天然纳米粒子.
- 目前在扩大BMV生产和确保稳定的局限性阻碍了它们的广泛应用.
研究的目的:
- 为高效的细菌膜囊泡 (BMV) 生产设计大肠杆菌.
- 开发一种可扩展的方法来制造治疗上可行的BMV.
主要方法:
- 通过通过 ompA信号与外膜融合 EutS 蛋白来诱导 *Escherichia coli* DH5α 的工程,从而诱导膜曲.
- 过度表达的脂肪乙基还原酶增加了两性脂肪酒精的产生,提高了BMV产量.
- 动态调节的酸甘油酶 (PGase) 表达以优化BMV释放.
主要成果:
- 实现了149.11倍的细菌膜囊泡 (BMV) 生产.
- 证明未经净化,高产量的BMV显著提高了先天免疫反应.
- 展示了这些BMV在治疗炎症性肠病 (IBD) 模型中的治疗效果.
结论:
- 开发了一种新的策略,以克服细菌膜囊泡 (BMV) 生产和隔离方面的挑战.
- 突出了工程细菌及其衍生的BMVs在炎症性肠病 (IBD) 治疗中的治疗潜力.
- 表明了这种工程系统在各种生物医学领域的广泛应用.
相关概念视频
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Inflammatory Bowel Disease IV: Pharmacological Management
110
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
110
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114


